Crispr Therapeutics shares owned by Derbend Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Derbend Asset Management
from 13F filings
Historical chart of Derbend Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Derbend Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Derbend Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $250k | 3.7k | 68.16 |
| 2023-12-31 | $235k | 3.8k | 62.60 |
| 2023-06-30 | $234k | 4.2k | 56.14 |
| 2022-09-30 | $300k | 4.6k | 65.43 |
| 2022-06-30 | $284k | 4.7k | 60.85 |
| 2022-03-31 | $888k | 12k | 75.81 |
| 2021-12-31 | $888k | 12k | 75.81 |
| 2021-09-30 | $1.6M | 14k | 111.94 |
| 2021-06-30 | $2.0M | 13k | 161.87 |